Anne Pieters

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters et al. · The Lancet · 2010 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +13

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer

Martin Reck, Alexander Luft, Aleksandra Szczęsna et al. · Journal of Clinical Oncology · 2016 · 537 citations

Medicine, Oncology, Pharmacotherapy +8

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032

Neal Ready, Anna F. Farago, Filippo de Braud et al. · Journal of Thoracic Oncology · 2018 · 378 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +7

CheckMate 451: A randomized, double-blind, phase III trial of nivolumab (nivo), nivo plus ipilimumab (ipi), or placebo as maintenance therapy in patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC) after first-line platinum-based doublet chemotherapy (PT-DC).

Neal Ready, Taofeek K. Owonikoko, Pieter E. Postmus et al. · Journal of Clinical Oncology · 2016 · 28 citations

Medicine, Oncology, Pharmacology +17

CheckMate 331: An open-label, randomized phase III trial of nivolumab versus chemotherapy in patients (pts) with relapsed small cell lung cancer (SCLC) after first-line platinum-based chemotherapy (PT-DC).

Leora Horn, Martin Reck, Scott Gettinger et al. · Journal of Clinical Oncology · 2016 · 25 citations

Medicine, Oncology, Pharmacology +17